文献速递青光眼

FOXC1调控前列腺素受体表达导致拉坦前列素反应减弱

FOXC1 Regulates Expression of Prostaglandin Receptors Leading to an Attenuated Response to Latanoprost.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究探讨FOXC1对前列腺素通路的影响,以解释Axenfeld-Rieger综合征中常见的前列腺素抵抗性青光眼表型。实验证实FOXC1结合并激活EP3前列腺素受体基因转录,FOXC1敲低后EP3蛋白和RNA水平显著降低,且拉坦前列素酸引起的纤连蛋白表达增加被FOXC1 siRNA共处理所消除。作者提出Axenfeld-Rieger综合征青光眼患者中FOXC1活性降低可解释其对前列腺素类药物的缺乏反应。

要点

  • FOXC1结合并激活EP3前列腺素受体基因转录。
  • FOXC1敲低导致EP3蛋白和RNA水平显著降低。
  • FOXC1敲低消除拉坦前列素酸诱导的纤连蛋白表达增加。

核心结论

  • 在用小干扰RNA敲低FOXC1的小梁网细胞系中,拉坦前列素信号传导被消除。
  • 作者提出Axenfeld-Rieger综合征青光眼患者中FOXC1活性水平较低可解释其对前列腺素类药物的缺乏反应。

研究设计与样本

  • 研究通过染色质免疫共沉淀-定量PCR和荧光素酶报告基因实验评估FOXC1与EP3前列腺素受体基因(PTGER3)的结合及转录活性。
  • 在永生化小梁网细胞(TM1)和HeLa细胞中用小干扰RNA降低FOXC1 mRNA,通过定量PCR和蛋白质印迹检测前列腺素受体表达变化。
  • TM1细胞用10 μM拉坦前列素酸和/或FOXC1小干扰RNA处理,通过定量PCR评估纤连蛋白和基质金属蛋白酶9表达。

主要发现

  • 染色质免疫共沉淀-定量PCR和荧光素酶实验证实FOXC1结合并激活EP3前列腺素受体基因转录。
  • HeLa和TM1细胞中FOXC1小干扰RNA敲低导致EP3蛋白和RNA水平显著降低。
  • TM1和HeLa细胞中FOXC1敲低时,其他前列腺素受体基因EP1(PTGER1)、EP2(PTGER2)、EP4(PTGER4)和FP(PTGFR)的RNA水平发生改变。
  • TM1细胞用10 μM拉坦前列素酸处理后纤连蛋白表达呈统计学显著增加,该增加被FOXC1小干扰RNA共处理所消除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study examines the effect of FOXC1 on the prostaglandin pathway in order to explore FOXC1's role in the prostaglandin-resistant glaucoma phenotype commonly seen in Axenfeld-Rieger syndrome. METHODS: Binding and transcriptional activity of FOXC1 to the gene coding for the EP3 prostaglandin receptor (PTGER3) were evaluated through ChIP-qPCR and luciferase-based assays. Immortalized trabecular meshwork cells (TM1) and HeLa cells had FOXC1 mRNA reduced via siRNA interference. qPCR and Western blot experiments were conducted to examine the changes in prostaglandin receptor expression brought about by lowered FOXC1. TM1 cells were then treated with 10 μM latanoprost acid and/or an siRNA for FOXC1. The expression of fibronectin and matrix metalloproteinase 9 were evaluated via qPCR in each treatment condition. RESULTS: ChIP-qPCR and luciferase experiments confirmed that FOXC1 binds to and activates transcription of the EP3 gene prostaglandin receptor. qPCR and Western experiments in HeLa and TM1 cells showed that FOXC1 siRNA knockdown results in significantly lowered EP3 levels (protein and RNA). In addition, RNA levels of the other prostaglandin receptor genes EP1 (PTGER1), EP2 (PTGER2), EP4 (PTGER4), and FP (PTGFR) were altered when FOXC1 was knocked down in TM1 and HeLa cells. Analysis of fibronectin expression in TM1 cells after treatment with 10 μM latanoprost acid showed a statistically significant increase in expression; this increase was abrogated by cotreatment with a siRNA for FOXC1. CONCLUSIONS: We show the abrogation of latanoprost signalling when FOXC1 is knocked down via siRNA in a trabecular meshwork cell line. We propose that the lower levels of active FOXC1 in Axenfeld-Rieger syndrome patients with glaucoma account for the lack of response to prostaglandin-based medications.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Doucette LP, Footz T, Walter MA, et al. FOXC1 Regulates Expression of Prostaglandin Receptors Leading to an Attenuated Response to Latanoprost. Invest Ophthalmol Vis Sci. 2018. PMID: 29847662. doi:10.1167/iovs.17-23223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。